Forsa Capital expects Avalon Pharma share price to rise 23% post-listing

30/01/2024 ِArgaam

Logo of Middle East Pharmaceutical Industries Co. (Avalon Pharma) Forsa Capital expects a 23% increase in the share

To Access this Content, Please Login Or Register

To Access this Content, Please Login or Subscribe

Most Read